Discovery of BP3 as an efficacious proteolysis targeting chimera (PROTAC) degrader of HSP90 for treating breast cancer-Reference-Cited by-同舟云学术

Discovery of BP3 as an efficacious proteolysis targeting chimera (PROTAC) degrader of HSP90 for treating breast cancer

Published:2022-01 Issue: Volume:228 Page:114013
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Liu Quanyu,Tu Guihui,Hu Yan,Jiang Qingna,Liu Jingwen,Lin Shanshan,Yu Zelei,Li Ge,Wu Xinhua,Tang Yuanling,Huang Xiuwang,Xu Jianhua,Liu Yang^ORCID,Wu Lixian

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference37 articles.

1. The multiple roles and therapeutic potential of molecular chaperones in prostate cancer;Hoter;Cancers,2019

2. Unusual suspects in the twilight zone between the Hsp90 interactome and carcinogenesis;Vartholomaiou;Adv. Cancer Res.,2016

3. Hsp90 and environmental stress transform the adaptive value of natural genetic variation;Jarosz;Science,2010

4. HSP90 and the chaperoning of cancer;Whitesell;Nat. Rev. Cancer,2005

5. A high-affinity conformation of Hsp90 confers tumor selectivity on Hsp90 inhibitors;Kamal;Nature,2003

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting HSP90 for Cancer Therapy: Current Progress and Emerging Prospects;Journal of Medicinal Chemistry;2024-09-10

2. TRAP1 drives smooth muscle cell senescence and promotes atherosclerosis via HDAC3-primed histone H4 lysine 12 lactylation;European Heart Journal;2024-08-01

3. PROTAC: Novel degradable approach for different targets to treat breast cancer;European Journal of Pharmaceutical Sciences;2024-07

4. Application and challenges of nitrogen heterocycles in PROTAC linker;European Journal of Medicinal Chemistry;2024-07

5. Recent developments of HSP90 inhibitors: an updated patent review (2020-present);Expert Opinion on Therapeutic Patents;2024-02